Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05548452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Study acronym: IMPACT
StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Site details revised at 2 of 2 sites
    v10
  2. Primary completion pushed from Nov 30, 2026 to May 2027
    • Study completion pushed from Dec 30, 2026 to Nov 2027
    v9
  3. Primary endpoints revised (3)v8
  4. Primary endpoints: 1 to 3v7
  5. Primary completion date: Nov 2026 to Nov 30, 2026
    • Study completion date: Dec 2026 to Dec 30, 2026
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Re-verified, no change to tracked fieldsv5
  2. Start date changed from estimate of Dec 2022 to Nov 21, 2022v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 2022 to Dec 2022
    • Site details revised at 2 of 2 sites
    v3
  4. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Trial Details
NCT Number NCT05548452
Lead Sponsor Virginia Commonwealth University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions
(from sponsor)		 Liver Disease; Alcohol-Related, Cirrhosis, Alcohol Use Disorder
Related terms Alcoholism, Fibrosis, Liver Diseases
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov